For patients admitted with COVID-19 infection, it is often difficult to predict if or when their clinical condition will deteriorate. However subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The primary aim of this study is to test the effect of continuous wireless vital signs monitoring with generation of real-time alerts through a purpose-built GUI, compared to standard EWS monitoring on the cumulative duration of any severely deviating vital signs
Device: WARD CSS
Wireless devices monitor vital signs continuously and transmit real-time data to an app that notifies clinical personnel when relevant deviations in vital signs occur This group will be monitored with standard Early Warning Score as well
Inclusion criteria
- Adult patients (≥18 years).
- Inclusion possible within 72 hours of admission, OR within 48 hours of discharge from
an ICU to a medical ward
- At least one expected overnight stay.
- Patient admitted with confirmed COVID-19 infection
Exclusion criteria
- Patient expected not to cooperate with study procedures.
- Allergy to plaster or silicone.
- Patients admitted for palliative care only (i.e. no active treatment).
- Patients previously enrolled in the studies WARD-COPD (H-18026653) or WARD-Surgery
(H-17033535).
- Inability to give informed consent.
Bispebjerg and Frederiksberg Hospital
Copenhagen, Denmark
Katja Grønbæk, MD, PhD-student, Principal Investigator
Bispebjerg Hospital